Pancreatic hypersecretion in liver disease.
Abnormally large duodenal aspirates have been reported in a large percentage of patients with cirrhosis of the liver. The source of this fluid has been variously ascribed to the liver and/or pancreas. The present study was undertaken to clarify its source. Eleven patients with cirrhosis of the liver and one with cholestatic hepatitis underwent an intraductal secretin test during endoscopic cannulation of the pancreatic duct. Six patients with cirrhosis had pancreatic hypersecretion ranging from 7.8 to 26.0 ml/min, while three patients demonstrated low secretory flow rates. Bile flow was negligible or nonexistent in ten patients, while in two others, larger but unmeasurable amounts of bile secretion were present. This study conclusively demonstrates that pancreatic hypersecretion may occur in patients with cirrhosis during secretin stimulation. Impaired metabolism of secretin or the associated pancreatic hypersecretion of early pancreatitis may be responsible for this finding.
D001646:Bile / Q000378:metabolism; D002404:Catheterization; D002908:Chronic Disease; D006505:Hepatitis / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology*; D010179:Pancreas / Q000503:physiopathology*; D010183:Pancreatic Ducts; D010189:Pancreatic Juice / Q000378:metabolism*; D010195:Pancreatitis / Q000503:physiopathology; D012633:Secretin; D012636:Secretory Rate
D012633:Secretin